Related Experiment Video
Updated: Mar 18, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Multiple mechanisms disrupt the let-7 microRNA family in neuroblastoma
John T Powers1, Kaloyan M Tsanov1, Daniel S Pearson1
1Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
Abstract:
Poor prognosis in neuroblastoma is associated with genetic amplification of MYCN. MYCN is itself a target of let-7, a tumour suppressor family of microRNAs implicated in numerous cancers. LIN28B, an inhibitor of let-7 biogenesis, is overexpressed in neuroblastoma and has been reported to regulate MYCN. Here we show, however, that LIN28B is dispensable in MYCN-amplified neuroblastoma cell lines, despite de-repression of let-7. We further demonstrate that MYCN messenger RNA levels in amplified disease are exceptionally high and sufficient to sponge let-7, which reconciles the dispensability of LIN28B. We found that genetic loss of let-7 is common in neuroblastoma, inversely associated with MYCN amplification, and independently associated with poor outcomes, providing a rationale for chromosomal loss patterns in neuroblastoma. We propose that let-7 disruption by LIN28B, MYCN sponging, or genetic loss is a unifying mechanism of neuroblastoma development with broad implications for cancer pathogenesis.
Insights
LIN28B is dispensable in neuroblastoma, as high MYCN RNA levels sponge tumor-suppressing let-7 microRNAs. let-7 disruption, through various mechanisms, drives neuroblastoma development and poor prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Neuroblastoma prognosis is linked to MYCN amplification.
- MYCN is targeted by let-7 tumor suppressor microRNAs.
- LIN28B inhibits let-7 biogenesis and is overexpressed in neuroblastoma.
Purpose of the Study:
- Investigate the role of LIN28B in MYCN-amplified neuroblastoma.
- Clarify the relationship between LIN28B, MYCN, and let-7.
- Determine the impact of let-7 disruption on neuroblastoma pathogenesis.
Main Methods:
- Analysis of MYCN-amplified neuroblastoma cell lines.
- Assessment of let-7 microRNA levels and activity.
- Correlation of genetic alterations with clinical outcomes.
Main Results:
- LIN28B is dispensable in MYCN-amplified neuroblastoma despite let-7 de-repression.
- High MYCN messenger RNA levels effectively sponge let-7.
- Genetic loss of let-7 is common, inversely associated with MYCN amplification, and linked to poor prognosis.
Conclusions:
- let-7 disruption, via LIN28B, MYCN sponging, or genetic loss, is a unifying mechanism in neuroblastoma.
- These findings have broad implications for understanding cancer pathogenesis.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi
Drugs that Destabilize Microtubules
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

